Immune Cell Epigenome Links Genetics and Life Experience

Key Takeaway Summary

• Immune cell responses vary widely between individuals due to differences in both genetic inheritance and life experiences.
• Epigenetic changes, specifically DNA methylation, record these genetic and environmental influences in immune cells.
• Researchers from the Salk Institute created a cell-type–specific immune epigenome atlas using blood samples from 110 individuals.
• Genetically inherited epigenetic markers (gDMRs) primarily affect long-term immune programming, especially in T and B cells.
• Experience-driven epigenetic markers (eDMRs) reflect infections, vaccinations, and environmental exposures, shaping flexible immune responses.
• The findings help explain variable clinical outcomes in infections such as COVID-19, influenza, HIV, and MRSA.
• This immune epigenome catalog may support precision diagnostics, prognosis, and personalized therapeutic strategies in infectious and immune-mediated diseases.

How the Immune Cell Epigenome Shapes Individual Responses

Why do patients infected with the same virus experience vastly different clinical outcomes? According to new research from the Salk Institute, the answer lies in the immune cell epigenome, a molecular layer that records both inherited genetics and lifetime exposures.

Published in Nature Genetics (January 27, 2026), the study presents a comprehensive cell-type–specific epigenetic atlas of immune cells, showing how DNA methylation patterns regulate immune behavior. While DNA sequences remain constant across cells, epigenetic markers determine which genes are active, shaping immune identity and response.

This distinction is especially relevant for clinicians managing variable responses to infections such as COVID-19, influenza, HIV-1, and MRSA, where risk prediction remains challenging.

Genetic vs Experiential Epigenetic Changes in Immune Cells

The researchers analyzed blood samples from 110 individuals with diverse medical histories, including prior infections, anthrax vaccination, and pesticide exposure. Four immune cell types were studied: T cells, B cells, monocytes, and natural killer cells.

Two distinct epigenetic patterns emerged:

• Genetically driven differentially methylated regions (gDMRs) clustered around stable gene regions, particularly in long-lived T and B cells.
• Experience-driven DMRs (eDMRs) appeared in regulatory regions that activate rapid immune responses, especially following infection or environmental exposure.
• These findings suggest that genetic inheritance establishes long-term immune programming, while life experience fine-tunes context-specific immune reactions.

Clinical Relevance for Precision Medicine and Risk Prediction

The immune epigenome catalog offers a roadmap for linking disease-associated genetic variants to the immune cells where pathology begins. By identifying which cell types are affected by specific epigenetic changes, clinicians may better understand disease susceptibility, prognosis, and therapeutic response.

Explore All Infectious Disease CME Conferences & Online Courses

With expanded datasets, this approach could support infection outcome prediction. For example, shared epigenetic markers among infection survivors could guide early risk assessment and targeted intervention, before severe symptoms develop.

For HCPs and nurses, this research reinforces the importance of integrating genetics, exposure history, and immune profiling into patient evaluation.

Source:

Salk Institute for Biological Studies